Normal Tissue Tolerance Dose Metrics for Radiation Therapy of Major Organs
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rubin, 1968
Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y
Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C
Trotti, 2003, CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6
Marcus, 1990, The incidence of myelitis after irradiation of the cervical spinal cord, Int J Radiat Oncol Biol Phys, 19, 3, 10.1016/0360-3016(90)90126-5
Marucci, 2004, Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis, Int J Radiat Oncol Biol Phys, 59, 551, 10.1016/j.ijrobp.2003.10.058
Merchant, 2006, Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma, Int J Radiat Oncol Biol Phys, 65, 210, 10.1016/j.ijrobp.2005.10.038
Armstrong, 2002, Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings, Neurology, 59, 40, 10.1212/WNL.59.1.40
Brown, 2003, Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination, J Clin Oncol, 21, 2519, 10.1200/JCO.2003.04.172
Laack, 2005, Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study, Int J Radiat Oncol Biol Phys, 63, 1175, 10.1016/j.ijrobp.2005.04.016
Torres, 2003, A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors, Neurology, 60, 1113, 10.1212/01.WNL.0000055862.20003.4A
Vigliani, 1996, A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results, Int J Radiat Oncol Biol Phys, 35, 527, 10.1016/S0360-3016(96)80015-0
Chin, 2001, Radiation necrosis following gamma knife surgery: A case-controlled comparison of treatment parameters and long-term clinical follow up, J Neurosurg, 94, 899, 10.3171/jns.2001.94.6.0899
Flickinger, 1991, Dose-volume considerations in radiosurgery, Stereotact Funct Neurosurg, 57, 99, 10.1159/000099560
Flickinger, 1991, Predicted dose-volume isoeffect curves for stereotactic radiosurgery with the 60Co gamma unit, Acta Oncol, 30, 363, 10.3109/02841869109092387
Levegrun, 2004, Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: Correlation with dose distribution parameters, Int J Radiat Oncol Biol Phys, 59, 796, 10.1016/j.ijrobp.2003.11.033
Liu, 2000, Analysis of related factors in complications of stereotactic radiosurgery in intracranial tumors, Stereotact Funct Neurosurg, 75, 129, 10.1159/000048394
Valery, 2003, Predictive factors of radiation necrosis after radiosurgery for cerebral metastases, Stereotact Funct Neurosurg, 81, 115, 10.1159/000075114
Debus, 1997, Brainstem tolerance to conformal radiotherapy of skull base tumors, Int J Radiat Oncol Biol Phys, 39, 967, 10.1016/S0360-3016(97)00364-7
Debus, 1999, Dose-volume tolerance of the brainstem after high-dose radiotherapy, Front Radiat Ther Oncol, 33, 305, 10.1159/000061211
Eisbruch, 2001, Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer, Int J Radiat Oncol Biol Phys, 50, 695, 10.1016/S0360-3016(01)01512-7
Eisbruch, 2003, Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer, World J Surg, 27, 832, 10.1007/s00268-003-7105-6
Eisbruch, 1999, Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, Int J Radiat Oncol Biol Phys, 45, 577, 10.1016/S0360-3016(99)00247-3
Chao, 2002, Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer, Semin Radiat Oncol, 12, 20, 10.1053/srao.2002.31359
Chao, 2001, A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results, Int J Radiat Oncol Biol Phys, 49, 907, 10.1016/S0360-3016(00)01441-3
Blanco, 2005, Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy, Int J Radiat Oncol Biol Phys, 62, 1055, 10.1016/j.ijrobp.2004.12.076
Amosson, 2003, Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique, Int J Radiat Oncol Biol Phys, 56, 136, 10.1016/S0360-3016(03)00093-2
Maes, 2002, Preservation of parotid function with uncomplicated conformal radiotherapy, Radiother Oncol, 63, 203, 10.1016/S0167-8140(02)00013-0
Munter, 2004, Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy, Int J Radiat Oncol Biol Phys, 58, 175, 10.1016/S0360-3016(03)01437-8
Pacholke, 2005, Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy, Am J Clin Oncol, 28, 351, 10.1097/01.coc.0000158826.88179.75
Roesink, 2005, A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials, Int J Radiat Oncol Biol Phys, 63, 1006, 10.1016/j.ijrobp.2005.04.023
Bussels, 2004, Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer, Radiother Oncol, 73, 297, 10.1016/j.radonc.2004.09.015
Braam, 2005, Long-term parotid gland function after radiotherapy, Int J Radiat Oncol Biol Phys, 62, 659, 10.1016/j.ijrobp.2004.12.015
Roesink, 2001, Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region, Int J Radiat Oncol Biol Phys, 51, 938, 10.1016/S0360-3016(01)01717-5
Jellema, 2005, Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?, Radiother Oncol, 77, 164, 10.1016/j.radonc.2005.10.002
McDonald, 1994, Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction, Int J Radiat Oncol Biol Phys, 29, 747, 10.1016/0360-3016(94)90562-2
Konings, 2005, Volume effects and region-dependent radiosensitivity of the parotid gland, Int J Radiat Oncol Biol Phys, 62, 1090, 10.1016/j.ijrobp.2004.12.035
Fisher, 2003, Phase III quality-of-life study results: Impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer—RTOG 97-09, Int J Radiat Oncol Biol Phys, 56, 832, 10.1016/S0360-3016(03)00121-4
Woynarowska, 1997, Pilocarpine, a salivary gland radioprotectant, does not inhibit cytotoxic effect of gamma-radiation on squamous cell carcinoma in vitro, Int J Radiat Oncol Biol Phys, 39, 751, 10.1016/S0360-3016(97)00367-2
Seppenwoolde, 2003, Comparing different NTCP models that predict the incidence of radiation pneumonitis, Int J Radiat Oncol Biol Phys, 55, 724, 10.1016/S0360-3016(02)03986-X
Kwa, 1998, Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5
Armstrong, 1997, Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer, Radiother Oncol, 44, 17, 10.1016/S0167-8140(97)01907-5
Yorke, 2005, Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study, Int J Radiat Oncol Biol Phys, 63, 672, 10.1016/j.ijrobp.2005.03.026
Yorke, 2002, Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy, Int J Radiat Oncol Biol Phys, 54, 329, 10.1016/S0360-3016(02)02929-2
Graham, 1999, Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 45, 323, 10.1016/S0360-3016(99)00183-2
Hernando, 2001, Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer, Int J Radiat Oncol Biol Phys, 51, 650, 10.1016/S0360-3016(01)01685-6
Tsujino, 2003, Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer, Int J Radiat Oncol Biol Phys, 55, 110, 10.1016/S0360-3016(02)03807-5
Bradley, 2005, Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma, Int J Radiat Oncol Biol Phys, 61, 318, 10.1016/j.ijrobp.2004.06.260
Hayman, 2001, Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial, J Clin Oncol, 19, 127, 10.1200/JCO.2001.19.1.127
Narayan, 2004, Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer, Lung Cancer, 44, 79, 10.1016/j.lungcan.2003.09.015
Rosenzweig, 2000, Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer, Cancer J, 6, 82
Marks, 2000, The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests, Cancer, 88, 2135, 10.1002/(SICI)1097-0142(20000501)88:9<2135::AID-CNCR20>3.0.CO;2-H
Marks, 1997, Physical and biological predictors of changes in whole-lung function following thoracic irradiation, Int J Radiat Oncol Biol Phys, 39, 563, 10.1016/S0360-3016(97)00343-X
Allen, 2003, Do dose-volume metrics predict pulmonary function changes in lung irradiation?, Int J Radiat Oncol Biol Phys, 55, 921, 10.1016/S0360-3016(02)04288-8
Fan, 2001, Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?, J Clin Oncol, 19, 543, 10.1200/JCO.2001.19.2.543
Fan, 2001, Relating radiation-induced regional lung injury to changes in pulmonary function tests, Int J Radiat Oncol Biol Phys, 51, 311, 10.1016/S0360-3016(01)01619-4
Mehta, 2005, Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention, Int J Radiat Oncol Biol Phys, 63, 5, 10.1016/j.ijrobp.2005.03.047
Garipagaoglu, 1999, The effect of patient-specific factors on radiation-induced regional lung injury, Int J Radiat Oncol Biol Phys, 45, 331, 10.1016/S0360-3016(99)00201-1
Anscher, 2003, Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy, Int J Radiat Oncol Biol Phys, 56, 988, 10.1016/S0360-3016(03)00184-6
Chen, 2002, Radiation pneumonitis and early circulatory cytokine markers, Semin Radiat Oncol, 12, 26, 10.1053/srao.2002.31360
Arpin, 2005, Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis, J Clin Oncol, 23, 8748, 10.1200/JCO.2005.01.7145
Gagliardi, 2001, Partial irradiation of the heart, Semin Radiat Oncol, 11, 224, 10.1053/srao.2001.23483
Adams, 2003, Radiation-associated cardiovascular disease, Crit Rev Oncol Hematol, 45, 55, 10.1016/S1040-8428(01)00227-X
Gagliardi, 1996, Long-term cardiac mortality after radiotherapy of breast cancer—Application of the relative seriality model, Br J Radiol, 69, 839, 10.1259/0007-1285-69-825-839
Eriksson, 2000, Long-term cardiac mortality following radiation therapy for Hodgkin’s disease: Analysis with the relative seriality model, Radiother Oncol, 55, 153, 10.1016/S0167-8140(00)00166-3
Singh, 2003, Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy, Int J Radiat Oncol Biol Phys, 55, 337, 10.1016/S0360-3016(02)03937-8
Maguire, 1999, Clinical and dosimetric predictors of radiation-induced esophageal toxicity, Int J Radiat Oncol Biol Phys, 45, 97, 10.1016/S0360-3016(99)00163-7
Ahn, 2005, Dosimetric and clinical predictors for radiation-induced esophageal injury, Int J Radiat Oncol Biol Phys, 61, 335, 10.1016/j.ijrobp.2004.06.014
Eifel, 1995, Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix, Int J Radiat Oncol Biol Phys, 32, 1289, 10.1016/0360-3016(95)00118-I
Lee, 1996, Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect, Int J Radiat Oncol Biol Phys, 35, 251, 10.1016/0360-3016(96)00064-8
Perez, 1999, Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation, Int J Radiat Oncol Biol Phys, 44, 855, 10.1016/S0360-3016(99)00111-X
Roeske, 1997, Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: A dosimetric analysis, Int J Radiat Oncol Biol Phys, 37, 351, 10.1016/S0360-3016(96)00490-7
Schultheiss, 1997, Late GI and GU complications in the treatment of prostate cancer, Int J Radiat Oncol Biol Phys, 37, 3, 10.1016/S0360-3016(96)00468-3
Fiorino, 2003, Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer, Int J Radiat Oncol Biol Phys, 57, 953, 10.1016/S0360-3016(03)00665-5
Huang, 2002, Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, 54, 1314, 10.1016/S0360-3016(02)03245-5
Jackson, 2001, Late rectal bleeding after conformal radiotherapy of prostate cancer, Int J Radiat Oncol Biol Phys, 49, 685, 10.1016/S0360-3016(00)01414-0
Kupelian, 2002, Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?, Cancer J, 8, 62, 10.1097/00130404-200201000-00011
Pollack, 2002, Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial, Int J Radiat Oncol Biol Phys, 53, 1097, 10.1016/S0360-3016(02)02829-8
Skwarchuk, 2000, Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response, Int J Radiat Oncol Biol Phys, 47, 103, 10.1016/S0360-3016(99)00560-X
Vargas, 2005, Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy, Int J Radiat Oncol Biol Phys, 62, 1297, 10.1016/j.ijrobp.2004.12.052
Vargas, 2005, Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity, Int J Radiat Oncol Biol Phys, 63, 141, 10.1016/j.ijrobp.2004.12.017
Wachter, 2001, Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors, Radiother Oncol, 59, 65, 10.1016/S0167-8140(01)00281-X
Pollack, 2005, Intact prostate cancer: Overview, 436
Lawrence, 1992, The use of 3-D dose volume analysis to predict radiation hepatitis, Int J Radiat Oncol Biol Phys, 23, 781, 10.1016/0360-3016(92)90651-W
Dawson, 2002, Analysis of radiation-induced liver disease using the Lyman NTCP model, Int J Radiat Oncol Biol Phys, 53, 810, 10.1016/S0360-3016(02)02846-8
Cheng, 2002, Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication, Int J Radiat Oncol Biol Phys, 54, 156, 10.1016/S0360-3016(02)02915-2
Xu, 2006, Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma, Int J Radiat Oncol Biol Phys, 65, 189, 10.1016/j.ijrobp.2005.11.034
Liang, 2006, Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance, Int J Radiat Oncol Biol Phys, 65, 426, 10.1016/j.ijrobp.2005.12.031
Carr, 2004, Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients, Liver Transpl, 10, S107, 10.1002/lt.20036
Lewandowski, 2005, 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging, J Vasc Interv Radiol, 16, 1641, 10.1097/01.RVI.0000179815.44868.66
Salem, 2005, Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival, J Vasc Interv Radiol, 16, 1627, 10.1097/01.RVI.0000184594.01661.81